These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8909812)

  • 1. Conservative surgery for aortic graft infection.
    Earnshaw JJ
    Cardiovasc Surg; 1996 Oct; 4(5):570-2. PubMed ID: 8909812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998).
    Hayes PD; Nasim A; London NJ; Sayers RD; Barrie WW; Bell PR; Naylor AR
    J Vasc Surg; 1999 Jul; 30(1):92-8. PubMed ID: 10394158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-impregnated grafts for aortic reconstruction.
    Lew W; Moore W
    Semin Vasc Surg; 2011 Dec; 24(4):211-9. PubMed ID: 22230676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of in situ prosthetic replacement for infected aortic grafts.
    Young RM; Cherry KJ; Davis PM; Gloviczki P; Bower TC; Panneton JM; Hallett JW
    Am J Surg; 1999 Aug; 178(2):136-40. PubMed ID: 10487266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial reconstruction with cryopreserved human allografts in the setting of infection: A single-center experience with midterm follow-up.
    Brown KE; Heyer K; Rodriguez H; Eskandari MK; Pearce WH; Morasch MD
    J Vasc Surg; 2009 Mar; 49(3):660-6. PubMed ID: 19268771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prosthetic graft infection, five years after ascending aortic replacement.
    Altarabsheh SE; Deo SV; Berbari E; Park SJ
    J Card Surg; 2012 Mar; 27(2):220-1. PubMed ID: 22340423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite vein graft reconstruction for infected descending aortic prosthesis.
    Okamoto H; Tamenishi A; Matsumura Y; Niimi T
    Ann Thorac Surg; 2012 Jun; 93(6):2061-3. PubMed ID: 22632507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections.
    Bandyk DF; Novotney ML; Johnson BL; Back MR; Roth SR
    J Surg Res; 2001 Jan; 95(1):44-9. PubMed ID: 11120634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results.
    Torsello G; Sandmann W; Gehrt A; Jungblut RM
    J Vasc Surg; 1993 Apr; 17(4):768-73. PubMed ID: 8464099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms.
    Bisdas T; Wilhelmi M; Haverich A; Teebken OE
    J Vasc Surg; 2011 May; 53(5):1274-1281.e4. PubMed ID: 21292430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.
    Seeger JM; Pretus HA; Welborn MB; Ozaki CK; Flynn TC; Huber TS
    J Vasc Surg; 2000 Sep; 32(3):451-9; discussion 460-1. PubMed ID: 10957651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of major aortic graft infection: preliminary experience with total graft excision and in situ replacement with a rifampicin bonded prosthesis.
    Naylor AR; Clark S; London NJ; Sayers RD; Macpherson DS; Barrie WW
    Eur J Vasc Endovasc Surg; 1995 Feb; 9(2):252-6. PubMed ID: 7627664
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment strategies and outcomes in patients with infected aortic endografts.
    Fatima J; Duncan AA; de Grandis E; Oderich GS; Kalra M; Gloviczki P; Bower TC
    J Vasc Surg; 2013 Aug; 58(2):371-9. PubMed ID: 23756338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infected lower extremity extra-anatomic bypass grafts: management of a serious complication in high-risk patients.
    de Virgilio C; Cherry KJ; Gloviczki P; Naessens J; Bower T; Hallett J; Pairolero P
    Ann Vasc Surg; 1995 Sep; 9(5):459-66. PubMed ID: 8541195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for management of infected aortic pathology based on current evidence.
    Stenson KM; Grima MJ; Loftus IM; Tripathi RK
    Semin Vasc Surg; 2019; 32(1-2):68-72. PubMed ID: 31540659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current technology for the treatment of infection following abdominal aortic aneurysm (AAA) fixation by endovascular repair (EVAR).
    Capoccia L; Mestres G; Riambau V
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):381-9. PubMed ID: 24518072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary aortoenteric fistula: contemporary outcome with use of extraanatomic bypass and infected graft excision.
    Kuestner LM; Reilly LM; Jicha DL; Ehrenfeld WK; Goldstone J; Stoney RJ
    J Vasc Surg; 1995 Feb; 21(2):184-95; discussion 195-6. PubMed ID: 7853593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In situ replacement with cryopreserved homografts for infected aortic prostheses].
    Morota T; Takamoto S
    Nihon Geka Gakkai Zasshi; 2009 Jan; 110(1):17-20. PubMed ID: 19227332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total prosthetic graft excision and extra-anatomic bypass.
    Jausseran JM; Stella N; Courbier R; Bergeron P; Ferdani M; Houel H; Rudondy P
    Eur J Vasc Endovasc Surg; 1997 Dec; 14 Suppl A():59-65. PubMed ID: 9467617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.